At The American Macular Degeneration Foundation (AMDF) we have been thinking a lot about how many of you in the AMD community may be concerned about being more at-risk from COVID-19  as described by the CDC (Centers for Disease Control) and how both fears and reality may affect your decisions about maintaining your AMD care. 

View Conference Coverage

Take a look at some of our conference coverage, visit our roundup section.

Conference Roundup

  1. Oct 15, 2019

Positive Efficacy Data Presented for Trial of hRPC Stem Cell Therapy

ReNeuron announced at the AAO 2019 meeting positive clinical data for its Phase 1/2a clinical trial of hRPC stem cell therapy for retinitis pigmentosa.

The ongoing trial is an open-label study to evaluate the safety, tolerability, and efficacy of…

Journal Scan

  1. Feb 08, 2020

Does Poor Visit Adherence Cause Vision Loss in Older Patients?

Missing just one ophthalmology appointment can cause vision loss for patients with age-related macular degeneration, highlighting the need for visit adherence, according to results from a Penn Medicine study published JAMA Ophthalmology.

Data from the Comparison of Age-related…